Alton Gregg H
Transaction: 06/20/2026
SELL
Change
-18,880
Price
Not reported
Filing
06/23/2026
Type
SELL
Novavax, Inc.
NVAX • Biotechnology
$10.22
▼ -0.12 (-1.16%)
Current price
EarningsLatest report: Jun 30, 2026
FAVORABLE PROFILEAttractiveConfidence: 70%
Quantitative profile — not an investment recommendation.
Quantitative profile — not an investment recommendation.Methodology
Analysis thesis: Strong business quality with supportive growth and cash-flow evidence. Valuation still matters, but the historical ratio profile is favorable.
Market Cap
$1.27B
Growth
13.1%
Cash Flow
1/5
Trend
Volatile
Evidence
Stable or improving margins · 39.2%Positive revenue growth · 27.1%Reasonable earnings multiple · 2.47Healthy liquidity · 2.13
Financial data as of: Jun 30, 2026, 12:00 AM UTCLast earnings update: Jun 30, 2026, 12:00 AM UTCLast profile update: Aug 7, 2026, 1:09 PM UTC
Company Snapshot
Key valuation, quality, financial strength, momentum and analyst data.
Price$10.22
Change-1.16%
Market Cap$1.27B
52W Range6.20 - 11.97
Beta2.43
Gross Margin93.67%
Oper. Margin50.14%
Profit Margin39.19%
Debt/Eq-1.95
Current Ratio2.13
Quick Ratio2.10
Revenue 5Y13.06%
Price$10.22
Change-1.16%
Market Cap$1.27B
52W Range6.20 - 11.97
Beta2.43
Gross Margin93.67%
Oper. Margin50.14%
Profit Margin39.19%
Debt/Eq-1.95
Current Ratio2.13
Quick Ratio2.10
Revenue 5Y13.06%
Target$18.00
Target Upside76.13%
Target Median$18.00
Target Range11.00 - 25.00
Volume4.83M
Avg Volume4.73M
EPS Surprise0.19
Investment DNA
How strong this company looks for long-term investors
80
out of 100
Business Quality
Margins, moat, returns
90/100
Financial Strength
Debt, cash, stability
95/100
Growth Potential
Revenue and expansion
95/100
Price Attractiveness
Cheap or expensive today
95/100
Why this score▼
Stable or improving margins · 39.2%Positive revenue growth · 27.1%Reasonable earnings multiple · 2.47Healthy liquidity · 2.13
Analyst view
Analyst sentiment and price target
Analyst sentiment
No vote count available
Bullish
0
Hold
0
Bearish
0
Price Target
2026-08-07
Low
$11.00
Mean
$18.00
Median
$18.00
High
$25.00
Insider Transactions
Recent executive and insider activity
Alton Gregg H
Transaction: 06/20/2026
BUY
Change
+18,880
Price
Not reported
Filing
06/23/2026
Type
BUY
MOTT DAVID M
Transaction: 06/20/2026
SELL
Change
-18,880
Price
Not reported
Filing
06/23/2026
Type
SELL
| Insider | Type | Change | Price | Transaction | Filing |
|---|---|---|---|---|---|
| Alton Gregg H | SELL | -18,880 | Not reported | 06/20/2026 | 06/23/2026 |
| Alton Gregg H | BUY | +18,880 | Not reported | 06/20/2026 | 06/23/2026 |
| MOTT DAVID M | SELL | -18,880 | Not reported | 06/20/2026 | 06/23/2026 |
| MOTT DAVID M | BUY | +18,880 | Not reported | 06/20/2026 | 06/23/2026 |
| MCGLYNN MARGARET G | SELL | -18,880 | Not reported | 06/20/2026 | 06/23/2026 |
| MCGLYNN MARGARET G | BUY | +18,880 | Not reported | 06/20/2026 | 06/23/2026 |
| DOUGLAS RICHARD | SELL | -18,880 | Not reported | 06/20/2026 | 06/23/2026 |
| DOUGLAS RICHARD | BUY | +18,880 | Not reported | 06/20/2026 | 06/23/2026 |
| King Rachel K. | SELL | -18,880 | Not reported | 06/20/2026 | 06/23/2026 |
| King Rachel K. | BUY | +18,880 | Not reported | 06/20/2026 | 06/23/2026 |
| Rodgers Richard J | SELL | -18,880 | Not reported | 06/20/2026 | 06/23/2026 |
| Rodgers Richard J | BUY | +18,880 | Not reported | 06/20/2026 | 06/23/2026 |
| Newton Charles W. | BUY | +14,180 | Not reported | 06/18/2026 | 06/23/2026 |
| Newton Charles W. | BUY | +21,270 | $9.13 | 06/18/2026 | 06/23/2026 |
| Shiver John W. | BUY | +14,180 | Not reported | 06/18/2026 | 06/23/2026 |
| Shiver John W. | BUY | +21,270 | $9.13 | 06/18/2026 | 06/23/2026 |
| Alton Gregg H | BUY | +14,180 | Not reported | 06/18/2026 | 06/23/2026 |
| Alton Gregg H | BUY | +21,270 | $9.13 | 06/18/2026 | 06/23/2026 |
| MOTT DAVID M | BUY | +14,180 | Not reported | 06/18/2026 | 06/23/2026 |
| MOTT DAVID M | BUY | +21,270 | $9.13 | 06/18/2026 | 06/23/2026 |